Prognosis associated with cutaneous melanoma metastases

Australasian Journal of Dermatology

Volumn 56, Issue 1, 2015, Pages 25-28

  Pan, Yan ^a   Haydon, Andrew M ^a   McLean, Catriona A ^a   McDonald, Priska B B ^a   Kelly, John W ^a  

^a The Alfred   (Australia)

Author keywords

cutaneous melanoma metastasis; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; CUTANEOUS MELANOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MELANOMA; METASTASIS; TUMOR LOCALIZATION; ADOLESCENT; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SECONDARY; SKIN TUMOR; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84923773862     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/ajd.12293     Document Type: Article

References (13)

1. Markowitz JS, Cosimi LA, Carey RW, et al. Prognosis after initial recurrence of cutaneous melanoma. Arch. Surg. 1991; 126: 703-707.
2. Buzzell RA, Zitelli JA,. Favorable prognostic factors in recurrent and metastatic melanoma. J. Am. Acad. Dermatol. 1996; 34: 798-803.
3. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 2009; 27: 6199-6206.
4. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 2001; 19: 3635-3648.
5. Roses DF, Karp NS, Oratz R, et al. Survival with regional and distant metastases from cutaneous malignant melanoma. Surg. Gynecol. Obstet. 1991; 172: 262-268.
6. Roses DF, Harris MN, Rigel D, et al. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann. Surg. 1983; 198: 65-69.
7. Messeguer F, Agustí-Mejías A, Traves V, et al. Mitotic rate and subcutaneous involvement are prognostic factors for survival after recurrence in patients with only locoregional skin metastasis as the first site of recurrence from cutaneous melanoma. J. Eur. Acad. Dermatol. Venereol. 2013; 27: 436-441.
8. Savoia P, Fava P, Nardò T, et al. Skin metastases of malignant melanoma: a clinical and prognostic survey. Melanoma Res. 2009; 19: 321-326.
9. Singletary SE, Tucker SL, Boddie AW Jr,. Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 1988; 61: 1437-1440.
10. Cascinelli N, Bufalino R, Marolda R, et al. Regional non-nodal metastases of cutaneous melanoma. Eur. J. Surg. Oncol. 1986; 12: 175-180.
11. Soong SJ, Harrison RA, McCarthy WH, et al. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J. Surg. Oncol. 1998; 67: 228-233.
12. Francken AB, Accortt NA, Shaw HM, et al. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma. Ann. Surg. Oncol. 2008; 15: 1476-1484.
13. National Health and Medical Research Council. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Canberra: NHMRC, 2008. Available from URL: https://www.nhmrc.gov.au/guidelines/publications/cp111. (Accessed 29 November 2014.)